BRAF and neoplasm: For example, Hao and Guo (2019) found that epidermal growth factor receptor mutation served as a novel prognostic factor related to immune infiltration in lower-grade glioma, while Zeng et al. (2016) suggested that the BRAF V600E mutation was associated with suppressive tumor immune microenvironment.